nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—HTR2B—Sorafenib—liver cancer	0.214	0.417	CbGbCtD
Ropinirole—HTR2C—Sorafenib—liver cancer	0.139	0.271	CbGbCtD
Ropinirole—CYP1A2—Sorafenib—liver cancer	0.0507	0.0987	CbGbCtD
Ropinirole—CYP2D6—Sorafenib—liver cancer	0.0418	0.0813	CbGbCtD
Ropinirole—CYP3A4—Sorafenib—liver cancer	0.0266	0.0517	CbGbCtD
Ropinirole—CYP2D6—Doxorubicin—liver cancer	0.0253	0.0493	CbGbCtD
Ropinirole—CYP3A4—Doxorubicin—liver cancer	0.0161	0.0314	CbGbCtD
Ropinirole—Face oedema—Doxorubicin—liver cancer	0.000309	0.00079	CcSEcCtD
Ropinirole—Gastritis—Epirubicin—liver cancer	0.000307	0.000782	CcSEcCtD
Ropinirole—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000306	0.00078	CcSEcCtD
Ropinirole—Muscular weakness—Epirubicin—liver cancer	0.000306	0.00078	CcSEcCtD
Ropinirole—Cardiac arrest—Doxorubicin—liver cancer	0.000305	0.000778	CcSEcCtD
Ropinirole—Dizziness—Sorafenib—liver cancer	0.000305	0.000777	CcSEcCtD
Ropinirole—Mood swings—Doxorubicin—liver cancer	0.000304	0.000775	CcSEcCtD
Ropinirole—Abdominal distension—Epirubicin—liver cancer	0.000301	0.000769	CcSEcCtD
Ropinirole—Ataxia—Doxorubicin—liver cancer	0.000301	0.000769	CcSEcCtD
Ropinirole—Influenza—Epirubicin—liver cancer	0.000299	0.000764	CcSEcCtD
Ropinirole—Asthma—Epirubicin—liver cancer	0.000299	0.000764	CcSEcCtD
Ropinirole—Dysphagia—Epirubicin—liver cancer	0.000299	0.000764	CcSEcCtD
Ropinirole—Dehydration—Doxorubicin—liver cancer	0.000298	0.000761	CcSEcCtD
Ropinirole—Eosinophilia—Epirubicin—liver cancer	0.000296	0.000756	CcSEcCtD
Ropinirole—Dry skin—Doxorubicin—liver cancer	0.000294	0.00075	CcSEcCtD
Ropinirole—Pancreatitis—Epirubicin—liver cancer	0.000294	0.000749	CcSEcCtD
Ropinirole—Vomiting—Sorafenib—liver cancer	0.000293	0.000747	CcSEcCtD
Ropinirole—Abdominal pain upper—Doxorubicin—liver cancer	0.000293	0.000747	CcSEcCtD
Ropinirole—Orthostatic hypotension—Doxorubicin—liver cancer	0.000293	0.000747	CcSEcCtD
Ropinirole—Hypokalaemia—Doxorubicin—liver cancer	0.000292	0.000744	CcSEcCtD
Ropinirole—Angina pectoris—Epirubicin—liver cancer	0.000292	0.000744	CcSEcCtD
Ropinirole—Rash—Sorafenib—liver cancer	0.000291	0.000741	CcSEcCtD
Ropinirole—Dermatitis—Sorafenib—liver cancer	0.00029	0.000741	CcSEcCtD
Ropinirole—Breast disorder—Doxorubicin—liver cancer	0.00029	0.000739	CcSEcCtD
Ropinirole—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000289	0.000737	CcSEcCtD
Ropinirole—Headache—Sorafenib—liver cancer	0.000289	0.000736	CcSEcCtD
Ropinirole—Bronchitis—Epirubicin—liver cancer	0.000288	0.000735	CcSEcCtD
Ropinirole—Nasopharyngitis—Doxorubicin—liver cancer	0.000287	0.000731	CcSEcCtD
Ropinirole—Gastritis—Doxorubicin—liver cancer	0.000284	0.000724	CcSEcCtD
Ropinirole—Muscular weakness—Doxorubicin—liver cancer	0.000283	0.000721	CcSEcCtD
Ropinirole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000283	0.000721	CcSEcCtD
Ropinirole—Dysuria—Epirubicin—liver cancer	0.00028	0.000714	CcSEcCtD
Ropinirole—Abdominal distension—Doxorubicin—liver cancer	0.000279	0.000712	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Epirubicin—liver cancer	0.000278	0.00071	CcSEcCtD
Ropinirole—Dysphagia—Doxorubicin—liver cancer	0.000277	0.000707	CcSEcCtD
Ropinirole—Influenza—Doxorubicin—liver cancer	0.000277	0.000707	CcSEcCtD
Ropinirole—Asthma—Doxorubicin—liver cancer	0.000277	0.000707	CcSEcCtD
Ropinirole—Pollakiuria—Epirubicin—liver cancer	0.000277	0.000706	CcSEcCtD
Ropinirole—Eosinophilia—Doxorubicin—liver cancer	0.000274	0.0007	CcSEcCtD
Ropinirole—Nausea—Sorafenib—liver cancer	0.000274	0.000698	CcSEcCtD
Ropinirole—Photosensitivity reaction—Epirubicin—liver cancer	0.000273	0.000697	CcSEcCtD
Ropinirole—Weight increased—Epirubicin—liver cancer	0.000273	0.000695	CcSEcCtD
Ropinirole—Pancreatitis—Doxorubicin—liver cancer	0.000272	0.000693	CcSEcCtD
Ropinirole—Weight decreased—Epirubicin—liver cancer	0.000271	0.000691	CcSEcCtD
Ropinirole—Hyperglycaemia—Epirubicin—liver cancer	0.00027	0.000689	CcSEcCtD
Ropinirole—Angina pectoris—Doxorubicin—liver cancer	0.00027	0.000689	CcSEcCtD
Ropinirole—Pneumonia—Epirubicin—liver cancer	0.000269	0.000685	CcSEcCtD
Ropinirole—Infestation NOS—Epirubicin—liver cancer	0.000267	0.000681	CcSEcCtD
Ropinirole—Infestation—Epirubicin—liver cancer	0.000267	0.000681	CcSEcCtD
Ropinirole—Bronchitis—Doxorubicin—liver cancer	0.000266	0.00068	CcSEcCtD
Ropinirole—Neuropathy peripheral—Epirubicin—liver cancer	0.000262	0.000668	CcSEcCtD
Ropinirole—Stomatitis—Epirubicin—liver cancer	0.00026	0.000664	CcSEcCtD
Ropinirole—Conjunctivitis—Epirubicin—liver cancer	0.00026	0.000662	CcSEcCtD
Ropinirole—Urinary tract infection—Epirubicin—liver cancer	0.00026	0.000662	CcSEcCtD
Ropinirole—Dysuria—Doxorubicin—liver cancer	0.000259	0.000661	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000258	0.000657	CcSEcCtD
Ropinirole—Pollakiuria—Doxorubicin—liver cancer	0.000256	0.000653	CcSEcCtD
Ropinirole—Haematuria—Epirubicin—liver cancer	0.000255	0.00065	CcSEcCtD
Ropinirole—Photosensitivity reaction—Doxorubicin—liver cancer	0.000253	0.000645	CcSEcCtD
Ropinirole—Hepatobiliary disease—Epirubicin—liver cancer	0.000253	0.000644	CcSEcCtD
Ropinirole—Weight increased—Doxorubicin—liver cancer	0.000252	0.000643	CcSEcCtD
Ropinirole—Epistaxis—Epirubicin—liver cancer	0.000252	0.000643	CcSEcCtD
Ropinirole—Weight decreased—Doxorubicin—liver cancer	0.000251	0.00064	CcSEcCtD
Ropinirole—Sinusitis—Epirubicin—liver cancer	0.00025	0.000639	CcSEcCtD
Ropinirole—Hyperglycaemia—Doxorubicin—liver cancer	0.00025	0.000638	CcSEcCtD
Ropinirole—Agranulocytosis—Epirubicin—liver cancer	0.000249	0.000636	CcSEcCtD
Ropinirole—Pneumonia—Doxorubicin—liver cancer	0.000248	0.000634	CcSEcCtD
Ropinirole—Infestation—Doxorubicin—liver cancer	0.000247	0.00063	CcSEcCtD
Ropinirole—Infestation NOS—Doxorubicin—liver cancer	0.000247	0.00063	CcSEcCtD
Ropinirole—Bradycardia—Epirubicin—liver cancer	0.000244	0.000623	CcSEcCtD
Ropinirole—Neuropathy peripheral—Doxorubicin—liver cancer	0.000242	0.000618	CcSEcCtD
Ropinirole—Haemoglobin—Epirubicin—liver cancer	0.000241	0.000615	CcSEcCtD
Ropinirole—Stomatitis—Doxorubicin—liver cancer	0.000241	0.000614	CcSEcCtD
Ropinirole—Rhinitis—Epirubicin—liver cancer	0.00024	0.000613	CcSEcCtD
Ropinirole—Urinary tract infection—Doxorubicin—liver cancer	0.00024	0.000613	CcSEcCtD
Ropinirole—Conjunctivitis—Doxorubicin—liver cancer	0.00024	0.000613	CcSEcCtD
Ropinirole—Haemorrhage—Epirubicin—liver cancer	0.00024	0.000612	CcSEcCtD
Ropinirole—Hypoaesthesia—Epirubicin—liver cancer	0.000238	0.000608	CcSEcCtD
Ropinirole—Pharyngitis—Epirubicin—liver cancer	0.000238	0.000607	CcSEcCtD
Ropinirole—Urinary tract disorder—Epirubicin—liver cancer	0.000237	0.000604	CcSEcCtD
Ropinirole—Oedema peripheral—Epirubicin—liver cancer	0.000236	0.000602	CcSEcCtD
Ropinirole—Haematuria—Doxorubicin—liver cancer	0.000236	0.000601	CcSEcCtD
Ropinirole—Connective tissue disorder—Epirubicin—liver cancer	0.000236	0.000601	CcSEcCtD
Ropinirole—Urethral disorder—Epirubicin—liver cancer	0.000235	0.000599	CcSEcCtD
Ropinirole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000234	0.000596	CcSEcCtD
Ropinirole—Epistaxis—Doxorubicin—liver cancer	0.000233	0.000595	CcSEcCtD
Ropinirole—Sinusitis—Doxorubicin—liver cancer	0.000232	0.000591	CcSEcCtD
Ropinirole—Visual impairment—Epirubicin—liver cancer	0.000231	0.000589	CcSEcCtD
Ropinirole—Agranulocytosis—Doxorubicin—liver cancer	0.000231	0.000588	CcSEcCtD
Ropinirole—Bradycardia—Doxorubicin—liver cancer	0.000226	0.000576	CcSEcCtD
Ropinirole—Eye disorder—Epirubicin—liver cancer	0.000224	0.000571	CcSEcCtD
Ropinirole—Tinnitus—Epirubicin—liver cancer	0.000223	0.00057	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—liver cancer	0.000223	0.000569	CcSEcCtD
Ropinirole—Flushing—Epirubicin—liver cancer	0.000222	0.000568	CcSEcCtD
Ropinirole—Cardiac disorder—Epirubicin—liver cancer	0.000222	0.000568	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—liver cancer	0.000222	0.000567	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—liver cancer	0.000222	0.000566	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—liver cancer	0.000221	0.000563	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—liver cancer	0.00022	0.000562	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—liver cancer	0.000219	0.000559	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—liver cancer	0.000218	0.000557	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—liver cancer	0.000218	0.000556	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—liver cancer	0.000217	0.000555	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—liver cancer	0.000217	0.000555	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—liver cancer	0.000216	0.000552	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—liver cancer	0.000216	0.000551	CcSEcCtD
Ropinirole—Chills—Epirubicin—liver cancer	0.000215	0.000549	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—liver cancer	0.000214	0.000546	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—liver cancer	0.000214	0.000545	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—liver cancer	0.000212	0.00054	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—liver cancer	0.00021	0.000536	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—liver cancer	0.000209	0.000532	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—liver cancer	0.000207	0.000529	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—liver cancer	0.000207	0.000528	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—liver cancer	0.000206	0.000525	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—liver cancer	0.000206	0.000525	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—liver cancer	0.000206	0.000525	CcSEcCtD
Ropinirole—Tension—Epirubicin—liver cancer	0.000205	0.000522	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—liver cancer	0.000204	0.000521	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—liver cancer	0.000203	0.000517	CcSEcCtD
Ropinirole—Back pain—Epirubicin—liver cancer	0.000202	0.000515	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—liver cancer	0.000201	0.000513	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—liver cancer	0.000201	0.000512	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—liver cancer	0.0002	0.000511	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—liver cancer	0.0002	0.00051	CcSEcCtD
Ropinirole—Chills—Doxorubicin—liver cancer	0.000199	0.000508	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—liver cancer	0.000198	0.000505	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—liver cancer	0.000197	0.000502	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—liver cancer	0.000196	0.0005	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—liver cancer	0.000194	0.000496	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—liver cancer	0.000194	0.000494	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—liver cancer	0.000193	0.000493	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—liver cancer	0.000193	0.000492	CcSEcCtD
Ropinirole—Agitation—Epirubicin—liver cancer	0.000192	0.000489	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—liver cancer	0.00019	0.000485	CcSEcCtD
Ropinirole—Tension—Doxorubicin—liver cancer	0.000189	0.000483	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—liver cancer	0.000189	0.000482	CcSEcCtD
Ropinirole—Malaise—Epirubicin—liver cancer	0.000188	0.00048	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—liver cancer	0.000188	0.000478	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—liver cancer	0.000187	0.000478	CcSEcCtD
Ropinirole—Syncope—Epirubicin—liver cancer	0.000187	0.000477	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—liver cancer	0.000187	0.000477	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—liver cancer	0.000187	0.000476	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—liver cancer	0.000186	0.000474	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—liver cancer	0.000184	0.00047	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—liver cancer	0.000183	0.000468	CcSEcCtD
Ropinirole—Cough—Epirubicin—liver cancer	0.000182	0.000465	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—liver cancer	0.000182	0.000464	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—liver cancer	0.000181	0.000461	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—liver cancer	0.00018	0.00046	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—liver cancer	0.000179	0.000457	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—liver cancer	0.000178	0.000455	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—liver cancer	0.000178	0.000453	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—liver cancer	0.000178	0.000453	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—liver cancer	0.000178	0.000453	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—liver cancer	0.000177	0.000453	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—liver cancer	0.000177	0.000452	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000176	0.00045	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—liver cancer	0.000175	0.000448	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—liver cancer	0.000174	0.000444	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—liver cancer	0.000174	0.000443	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—liver cancer	0.000173	0.000443	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—liver cancer	0.000173	0.000442	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—liver cancer	0.000173	0.000441	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—liver cancer	0.000172	0.000438	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—liver cancer	0.000171	0.000435	CcSEcCtD
Ropinirole—Oedema—Epirubicin—liver cancer	0.00017	0.000434	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—liver cancer	0.00017	0.000433	CcSEcCtD
Ropinirole—Infection—Epirubicin—liver cancer	0.000169	0.000432	CcSEcCtD
Ropinirole—Cough—Doxorubicin—liver cancer	0.000168	0.00043	CcSEcCtD
Ropinirole—Shock—Epirubicin—liver cancer	0.000168	0.000427	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—liver cancer	0.000167	0.000427	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—liver cancer	0.000167	0.000426	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—liver cancer	0.000167	0.000425	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—liver cancer	0.000167	0.000425	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—liver cancer	0.000166	0.000424	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—liver cancer	0.000165	0.000422	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—liver cancer	0.000165	0.00042	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—liver cancer	0.000164	0.000419	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—liver cancer	0.000164	0.000419	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—liver cancer	0.000164	0.000419	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—liver cancer	0.000164	0.000418	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000163	0.000416	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—liver cancer	0.000162	0.000414	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—liver cancer	0.000162	0.000414	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—liver cancer	0.000161	0.00041	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—liver cancer	0.000159	0.000406	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—liver cancer	0.000159	0.000405	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—liver cancer	0.000158	0.000402	CcSEcCtD
Ropinirole—Infection—Doxorubicin—liver cancer	0.000157	0.000399	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000155	0.000396	CcSEcCtD
Ropinirole—Shock—Doxorubicin—liver cancer	0.000155	0.000396	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—liver cancer	0.000155	0.000394	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—liver cancer	0.000154	0.000394	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—liver cancer	0.000154	0.000393	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—liver cancer	0.000154	0.000392	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—liver cancer	0.000153	0.00039	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—liver cancer	0.000153	0.00039	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—liver cancer	0.000152	0.000389	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—liver cancer	0.000152	0.000387	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—liver cancer	0.000151	0.000386	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—liver cancer	0.00015	0.000383	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—liver cancer	0.00015	0.000382	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—liver cancer	0.000148	0.000378	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—liver cancer	0.000147	0.000376	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—liver cancer	0.000147	0.000375	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—liver cancer	0.000147	0.000375	CcSEcCtD
Ropinirole—Pain—Epirubicin—liver cancer	0.000146	0.000372	CcSEcCtD
Ropinirole—Constipation—Epirubicin—liver cancer	0.000146	0.000372	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000144	0.000366	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—liver cancer	0.000143	0.000364	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—liver cancer	0.000141	0.000361	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—liver cancer	0.00014	0.000358	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—liver cancer	0.00014	0.000358	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—liver cancer	0.00014	0.000357	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—liver cancer	0.000139	0.000355	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—liver cancer	0.000139	0.000354	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—liver cancer	0.000137	0.000349	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000136	0.000347	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—liver cancer	0.000136	0.000347	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—liver cancer	0.000135	0.000345	CcSEcCtD
Ropinirole—Pain—Doxorubicin—liver cancer	0.000135	0.000344	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—liver cancer	0.000135	0.000344	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—liver cancer	0.000135	0.000343	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—liver cancer	0.000135	0.000343	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—liver cancer	0.00013	0.000331	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—liver cancer	0.000129	0.000329	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—liver cancer	0.000125	0.00032	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—liver cancer	0.000125	0.000319	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—liver cancer	0.000125	0.000318	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—liver cancer	0.000125	0.000318	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—liver cancer	0.000122	0.000312	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—liver cancer	0.00012	0.000307	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—liver cancer	0.000117	0.000297	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—liver cancer	0.000116	0.000296	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—liver cancer	0.000113	0.000288	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—liver cancer	0.000113	0.000287	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—liver cancer	0.000111	0.000284	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—liver cancer	0.000108	0.000276	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—liver cancer	0.000108	0.000275	CcSEcCtD
Ropinirole—Rash—Epirubicin—liver cancer	0.000107	0.000274	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—liver cancer	0.000107	0.000274	CcSEcCtD
Ropinirole—Headache—Epirubicin—liver cancer	0.000107	0.000272	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—liver cancer	0.000104	0.000266	CcSEcCtD
Ropinirole—Nausea—Epirubicin—liver cancer	0.000101	0.000258	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—liver cancer	0.0001	0.000256	CcSEcCtD
Ropinirole—Rash—Doxorubicin—liver cancer	9.93e-05	0.000253	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—liver cancer	9.92e-05	0.000253	CcSEcCtD
Ropinirole—Headache—Doxorubicin—liver cancer	9.87e-05	0.000252	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—liver cancer	9.36e-05	0.000239	CcSEcCtD
Ropinirole—ADRA2C—Signaling by GPCR—HRAS—liver cancer	8.53e-06	9.05e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—liver cancer	8.52e-06	9.04e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CASP3—liver cancer	8.49e-06	9.01e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	8.48e-06	8.99e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2—liver cancer	8.48e-06	8.99e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CASP3—liver cancer	8.45e-06	8.96e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—liver cancer	8.43e-06	8.95e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2—liver cancer	8.43e-06	8.95e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—liver cancer	8.42e-06	8.93e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—liver cancer	8.39e-06	8.9e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	8.38e-06	8.89e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—liver cancer	8.38e-06	8.89e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—liver cancer	8.36e-06	8.87e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	8.32e-06	8.83e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—liver cancer	8.31e-06	8.82e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RAF1—liver cancer	8.3e-06	8.81e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—liver cancer	8.3e-06	8.8e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	8.29e-06	8.8e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	8.28e-06	8.79e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—liver cancer	8.27e-06	8.77e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—liver cancer	8.26e-06	8.77e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—JUN—liver cancer	8.25e-06	8.75e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	8.24e-06	8.75e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	8.23e-06	8.73e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—liver cancer	8.23e-06	8.73e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—liver cancer	8.22e-06	8.72e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CASP3—liver cancer	8.22e-06	8.72e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—liver cancer	8.21e-06	8.71e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—JUN—liver cancer	8.2e-06	8.7e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—liver cancer	8.2e-06	8.7e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—liver cancer	8.19e-06	8.68e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CTNNB1—liver cancer	8.18e-06	8.68e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—liver cancer	8.17e-06	8.67e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RAF1—liver cancer	8.17e-06	8.67e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—liver cancer	8.16e-06	8.66e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—liver cancer	8.15e-06	8.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—liver cancer	8.15e-06	8.65e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CTNNB1—liver cancer	8.14e-06	8.64e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CB—liver cancer	8.1e-06	8.6e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MTOR—liver cancer	8.1e-06	8.6e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK8—liver cancer	8.08e-06	8.58e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—liver cancer	8.06e-06	8.55e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—liver cancer	8.05e-06	8.54e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—liver cancer	8.04e-06	8.53e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—liver cancer	8.02e-06	8.51e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYCS—liver cancer	8.02e-06	8.51e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—liver cancer	8e-06	8.48e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CDKN1A—liver cancer	7.99e-06	8.48e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—liver cancer	7.98e-06	8.47e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP1A1—liver cancer	7.98e-06	8.47e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—JUN—liver cancer	7.98e-06	8.47e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MTOR—liver cancer	7.97e-06	8.46e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CB—liver cancer	7.97e-06	8.46e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CDKN1A—liver cancer	7.95e-06	8.44e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	7.92e-06	8.4e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—liver cancer	7.91e-06	8.39e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GGT1—liver cancer	7.87e-06	8.35e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GOT1—liver cancer	7.87e-06	8.35e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK8—liver cancer	7.8e-06	8.28e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—liver cancer	7.78e-06	8.26e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—liver cancer	7.76e-06	8.24e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK8—liver cancer	7.76e-06	8.24e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—liver cancer	7.74e-06	8.21e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—liver cancer	7.74e-06	8.21e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	7.74e-06	8.21e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—liver cancer	7.71e-06	8.18e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—liver cancer	7.69e-06	8.16e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—liver cancer	7.61e-06	8.08e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—liver cancer	7.61e-06	8.07e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1B—liver cancer	7.61e-06	8.07e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—liver cancer	7.59e-06	8.05e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—liver cancer	7.55e-06	8.01e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK8—liver cancer	7.55e-06	8.01e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—liver cancer	7.54e-06	8e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—liver cancer	7.53e-06	7.99e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—liver cancer	7.52e-06	7.98e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	7.49e-06	7.94e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1B—liver cancer	7.48e-06	7.94e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—liver cancer	7.46e-06	7.92e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—liver cancer	7.45e-06	7.91e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—liver cancer	7.44e-06	7.9e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MTHFR—liver cancer	7.44e-06	7.89e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RAF1—liver cancer	7.43e-06	7.88e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—liver cancer	7.41e-06	7.86e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—liver cancer	7.4e-06	7.85e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—liver cancer	7.39e-06	7.84e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—liver cancer	7.39e-06	7.84e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CG—liver cancer	7.38e-06	7.83e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—liver cancer	7.33e-06	7.78e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—liver cancer	7.32e-06	7.77e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARA—liver cancer	7.3e-06	7.74e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—liver cancer	7.3e-06	7.74e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—liver cancer	7.29e-06	7.73e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—liver cancer	7.27e-06	7.71e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—liver cancer	7.26e-06	7.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MTOR—liver cancer	7.25e-06	7.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	7.25e-06	7.7e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—JUN—liver cancer	7.24e-06	7.68e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—liver cancer	7.2e-06	7.64e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CTNNB1—liver cancer	7.19e-06	7.62e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—liver cancer	7.17e-06	7.6e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—liver cancer	7.15e-06	7.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—liver cancer	7.14e-06	7.57e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—liver cancer	7.13e-06	7.57e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—JUN—liver cancer	7.12e-06	7.56e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—liver cancer	7.12e-06	7.56e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—liver cancer	7.12e-06	7.56e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—liver cancer	7.1e-06	7.53e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CTNNB1—liver cancer	7.07e-06	7.5e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—liver cancer	7.07e-06	7.5e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—liver cancer	7.04e-06	7.47e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—liver cancer	7.03e-06	7.46e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—liver cancer	7.03e-06	7.46e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1A—liver cancer	7.02e-06	7.45e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—liver cancer	6.98e-06	7.4e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—liver cancer	6.97e-06	7.4e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—liver cancer	6.97e-06	7.4e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—liver cancer	6.94e-06	7.36e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—liver cancer	6.93e-06	7.35e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—liver cancer	6.93e-06	7.35e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1A—liver cancer	6.91e-06	7.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—liver cancer	6.9e-06	7.32e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—liver cancer	6.87e-06	7.28e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK8—liver cancer	6.85e-06	7.27e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—liver cancer	6.85e-06	7.27e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—liver cancer	6.83e-06	7.25e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—liver cancer	6.83e-06	7.25e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	6.81e-06	7.22e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK8—liver cancer	6.74e-06	7.15e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	6.73e-06	7.15e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—liver cancer	6.73e-06	7.13e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—liver cancer	6.72e-06	7.13e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—liver cancer	6.71e-06	7.12e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—liver cancer	6.68e-06	7.09e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—liver cancer	6.67e-06	7.08e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—liver cancer	6.66e-06	7.07e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—liver cancer	6.63e-06	7.03e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—liver cancer	6.63e-06	7.03e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—liver cancer	6.61e-06	7.02e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—liver cancer	6.59e-06	7e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—liver cancer	6.58e-06	6.98e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.56e-06	6.96e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—liver cancer	6.54e-06	6.94e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—liver cancer	6.54e-06	6.94e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—liver cancer	6.51e-06	6.91e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—liver cancer	6.5e-06	6.89e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—liver cancer	6.5e-06	6.89e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CD—liver cancer	6.49e-06	6.88e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—JUN—liver cancer	6.48e-06	6.88e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—liver cancer	6.46e-06	6.85e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—liver cancer	6.44e-06	6.83e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	6.43e-06	6.82e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—liver cancer	6.42e-06	6.81e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—liver cancer	6.41e-06	6.8e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—liver cancer	6.4e-06	6.79e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—liver cancer	6.4e-06	6.79e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—liver cancer	6.34e-06	6.73e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—liver cancer	6.33e-06	6.72e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—liver cancer	6.33e-06	6.71e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—liver cancer	6.31e-06	6.69e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	6.28e-06	6.67e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—liver cancer	6.26e-06	6.64e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CG—liver cancer	6.25e-06	6.63e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—liver cancer	6.25e-06	6.63e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—liver cancer	6.22e-06	6.6e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—liver cancer	6.16e-06	6.54e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—liver cancer	6.16e-06	6.54e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A1—liver cancer	6.16e-06	6.53e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—liver cancer	6.14e-06	6.52e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK8—liver cancer	6.13e-06	6.51e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—liver cancer	6.12e-06	6.5e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—liver cancer	6.12e-06	6.49e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—liver cancer	6.09e-06	6.46e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—liver cancer	6.05e-06	6.42e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—liver cancer	6.03e-06	6.4e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—liver cancer	6.03e-06	6.4e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—liver cancer	5.97e-06	6.34e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—liver cancer	5.94e-06	6.3e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—liver cancer	5.93e-06	6.29e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	5.83e-06	6.18e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—liver cancer	5.82e-06	6.17e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—liver cancer	5.81e-06	6.16e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—liver cancer	5.79e-06	6.15e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MTHFR—liver cancer	5.74e-06	6.09e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—liver cancer	5.73e-06	6.08e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—liver cancer	5.72e-06	6.07e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—liver cancer	5.71e-06	6.06e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—liver cancer	5.67e-06	6.01e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—liver cancer	5.66e-06	6.01e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CB—liver cancer	5.65e-06	6e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—liver cancer	5.64e-06	5.98e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARA—liver cancer	5.63e-06	5.98e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—liver cancer	5.63e-06	5.97e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—liver cancer	5.61e-06	5.95e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—liver cancer	5.6e-06	5.94e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CD—liver cancer	5.49e-06	5.83e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	5.44e-06	5.78e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—liver cancer	5.44e-06	5.78e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—liver cancer	5.42e-06	5.75e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—liver cancer	5.42e-06	5.75e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—liver cancer	5.39e-06	5.72e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—liver cancer	5.38e-06	5.71e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—liver cancer	5.35e-06	5.67e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—liver cancer	5.32e-06	5.64e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—liver cancer	5.29e-06	5.61e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—liver cancer	5.29e-06	5.61e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—liver cancer	5.27e-06	5.6e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—liver cancer	5.27e-06	5.59e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—liver cancer	5.21e-06	5.53e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—liver cancer	5.21e-06	5.52e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—liver cancer	5.2e-06	5.51e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—liver cancer	5.18e-06	5.49e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—liver cancer	5.16e-06	5.48e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—liver cancer	5.04e-06	5.34e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—liver cancer	4.98e-06	5.29e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—liver cancer	4.96e-06	5.26e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—liver cancer	4.94e-06	5.24e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—liver cancer	4.86e-06	5.16e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CG—liver cancer	4.82e-06	5.12e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—liver cancer	4.82e-06	5.12e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—liver cancer	4.81e-06	5.11e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CB—liver cancer	4.79e-06	5.08e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—liver cancer	4.78e-06	5.07e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—liver cancer	4.76e-06	5.05e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—liver cancer	4.7e-06	4.99e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—liver cancer	4.66e-06	4.94e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—liver cancer	4.6e-06	4.88e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—liver cancer	4.57e-06	4.85e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—liver cancer	4.57e-06	4.85e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—liver cancer	4.5e-06	4.77e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—liver cancer	4.45e-06	4.72e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	4.42e-06	4.69e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—liver cancer	4.37e-06	4.64e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—liver cancer	4.32e-06	4.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—liver cancer	4.3e-06	4.57e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—liver cancer	4.28e-06	4.54e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CD—liver cancer	4.24e-06	4.5e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—liver cancer	4.19e-06	4.44e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—liver cancer	4.09e-06	4.34e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—liver cancer	4.04e-06	4.28e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—liver cancer	3.97e-06	4.21e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—liver cancer	3.92e-06	4.15e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CB—liver cancer	3.7e-06	3.92e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—liver cancer	3.61e-06	3.83e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—liver cancer	3.45e-06	3.66e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—liver cancer	2.92e-06	3.1e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—liver cancer	2.82e-06	2.99e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—liver cancer	2.39e-06	2.53e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—liver cancer	2.25e-06	2.39e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—liver cancer	1.84e-06	1.95e-05	CbGpPWpGaD
